Sign in

CIK 0001789769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Instil Bio, Inc.

Sign in to watch
Ticker
TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
832072195
Phone
(972) 499-3350
Business address
3963 MAPLE AVENUE, SUITE 350, DALLAS, TX, 75219
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-23 Shah Nimish P Director Conversion +510,030 510,030
2021-03-23 Shah Nimish P Director Conversion +430,431 5,531,297
2021-03-23 Shah Nimish P Director Conversion +43,033 553,063
2021-03-23 Shah Nimish P Director Conversion +480,716 480,716
2021-03-23 Shah Nimish P Director Purchase +104,640 $20.00 $2.1M 5,635,937
2021-03-23 Shah Nimish P Director Purchase +10,470 $20.00 $209K 563,533
2021-03-23 Shah Nimish P Director Purchase +116,880 $20.00 $2.3M 597,596
2021-03-23 Shah Nimish P Director Purchase +48,390 $20.00 $968K 48,390
2021-03-23 Shah Nimish P Director Purchase +19,620 $20.00 $392K 19,620
2021-03-23 Shah Nimish P Director Conversion · Series B Preferred Stock −4,250,722 0
2021-03-23 Shah Nimish P Director Conversion · Series B Preferred Stock −425,025 0
2021-03-23 Shah Nimish P Director Conversion · Series C Preferred Stock −358,693 0
2021-03-23 Shah Nimish P Director Conversion · Series C Preferred Stock −35,861 0
2021-03-23 Shah Nimish P Director Conversion · Series C Preferred Stock −400,597 0
2021-03-23 Nielsen Jack Director Conversion +11,709,696 11,709,696
2021-03-23 Nielsen Jack Director Conversion +477,091 12,186,787
2021-03-23 Nielsen Jack Director Purchase +300,000 $20.00 $6.0M 12,486,787
2021-03-23 Nielsen Jack Director Conversion · Series B Preferred Stock −9,758,080 0
2021-03-23 Nielsen Jack Director Conversion · Series C Preferred Stock −397,576 0
2021-03-23 McGaughy R Kent Jr Director Conversion +7,074,608 7,074,608

Page 4 of 6 · 108 trades